title: Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes.
abstract: We compared the effects of dialysate composition on changes in intermediary metabolites, acid-base balance, and potassium removal during hemodialysis. Patients were dialyzed against dialysates containing acetate or bicarbonate, each with or without glucose, in a four-way cross-over study. Dialysates containing acetate were associated with significant perturbations in intermediary metabolism, including increases in blood citrate, acetoacetate and beta-hydroxybutyrate and a decrease in pyruvate. In contrast, bicarbonate-containing dialysates caused minimal perturbations in intermediary metabolism. Addition of glucose to the dialysate decreased the changes in intermediary metabolites; however, the magnitude of this effect was less than that observed for the change from acetate to bicarbonate. Use of acetate also resulted in lower post-dialysis blood-concentrations of base equivalents than obtained with bicarbonate; this difference was unaffected by the presence or absence of glucose. Although pre- and post-dialysis potassium concentrations were unaffected by the dialysate formulation, total potassium removal was significantly greater when glucose was omitted from the dialysate. Our results suggest that both bicarbonate and glucose should be included in the dialysate, particularly for those patients whose capacity for metabolism may be limited because of highly efficient dialysis, intercurrent illness, or starvation. However, addition of glucose to the dialysate may require a reduction in dialysate potassium to maintain proper potassium homeostasis.
authors.forename: R A
authors.initials: RA
authors.lastname: Ward
authors.forename: R L
authors.initials: RL
authors.lastname: Wathen
authors.forename: T E
authors.initials: TE
authors.lastname: Williams
authors.forename: G B
authors.initials: GB
authors.lastname: Harding
mesh_terms: D000085:Acetates / Q000494:pharmacology; D000136:Acid-Base Equilibrium / Q000187:drug effects; D001639:Bicarbonates / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism; D004573:Electrolytes / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000097:blood; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism*; D006435:Renal Dialysis
chemical_list: D000085:Acetates; D001639:Bicarbonates; D001786:Blood Glucose; D004573:Electrolytes; D007328:Insulin; D005947:Glucose; D011188:Potassium